Skip to main content
TipRanks
Go Ultimate75% OFF

Suraksha Diagnostic Ltd. (SURAKSHA) Stock Price & Analysis

2 Followers

SURAKSHA Stock Chart & Stats

₹341.70₹1.05(0.31%)
At close: 3:30 PM GMT+5:30
₹300₹325₹350Aug 17Aug 31Sep 15Sep 28Oct 12Oct 26Nov 9
Day’s Range
INR 338.70 - INR 355.00
52-Week Range
INR 224.10 - INR 381.10
Previous Close
INR 340.65
Volume
N/A
Average Volume (3M)
8,412
Market Cap
INR 17.74B
Enterprise Value
INR 19.88B
Total Cash (Recent Filing)
INR 263.48M
Total Debt (Recent Filing)
INR 0
Price to Earnings (P/E)
42.6
Beta
0.86
Next Earnings
Feb 13, 2027 (Est.)
EPS Estimate
N/A
Dividend Yield
0.29%

Bulls Say, Bears Say

Bulls Say

Sustained Revenue Growth

Revenue growth remained solid across three consecutive fiscal years after the FY23 contraction, indicating continued expansion in diagnostic testing demand. Sustained top-line growth can support operating scale, broaden the customer base, and provide a durable foundation for future earnings development.

Healthy Operating Profitability

Healthy operating and EBITDA margins show that Suraksha converts diagnostic service revenue into meaningful operating earnings. This profitability provides internal resources for network development and equipment investment while offering some resilience if revenue growth moderates over the next several quarters.

Strong Operating Cash Generation

Operating cash flow exceeding reported net income supports the quality of accounting earnings and demonstrates that the core business is generating cash from operations. This strengthens funding capacity for routine investment and reduces reliance on external financing to sustain operations.

Bears Say

Margin Compression And Volatility

The sharp FY26 gross-margin decline and lower net margin show that profitability has not been consistently stable despite continued revenue growth. Persistent margin pressure could reduce earnings scalability and weaken the company’s ability to convert market expansion into durable bottom-line growth.

Rising Leverage And Lower Returns

Higher leverage alongside declining return on equity indicates that incremental balance-sheet investment is currently producing lower returns. If this pattern persists, interest obligations and reduced capital efficiency could constrain financial flexibility and limit funding available for expansion.

Weak Free-Cash-Flow Conversion

Although operating cash generation is positive, converting earnings into free cash flow remains weak and uneven. Low free-cash-flow conversion may reflect substantial capital spending or working-capital needs, limiting discretionary cash available for debt reduction, shareholder returns, or growth initiatives.

Suraksha Diagnostic Ltd. News

SURAKSHA FAQ

What was Suraksha Diagnostic Ltd.’s price range in the past 12 months?
Suraksha Diagnostic Ltd. lowest stock price was ₹224.10 and its highest was ₹381.10 in the past 12 months.
What is Suraksha Diagnostic Ltd.’s market cap?
Suraksha Diagnostic Ltd.’s market cap is ₹17.74B.
When is Suraksha Diagnostic Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Suraksha Diagnostic Ltd.’s earnings last quarter?
Suraksha Diagnostic Ltd. released its earnings results on Nov 10, 2026. The company reported ₹2.882 earnings per share for the quarter.
Is Suraksha Diagnostic Ltd. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Suraksha Diagnostic Ltd. pay dividends?
Suraksha Diagnostic Ltd. pays a dividend of ₹0.5 which represents an annual dividend yield of 0.29%. See more information on Suraksha Diagnostic Ltd. dividends here
What is Suraksha Diagnostic Ltd.’s EPS estimate?
Suraksha Diagnostic Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Suraksha Diagnostic Ltd. have?
Suraksha Diagnostic Ltd. has 52,080,757 shares outstanding.
What happened to Suraksha Diagnostic Ltd.’s price movement after its last earnings report?
Suraksha Diagnostic Ltd. reported an EPS of ₹2.882 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Suraksha Diagnostic Ltd.?
Currently, no hedge funds are holding shares in IN:SURAKSHA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology